Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,275) with videos related to
Page
of 128
Sort By:
Nucleic Acids Research
|
November 26, 1999
A multiple-capillary electrophoresis system for small-scale DNA sequencing and analysis
J Zhang, K O Voss, D F Shaw, et al.
American Heart Journal
|
August 25, 2015
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus
Eldrin F Lewis, Brian Claggett, Patrick S Parfrey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 9, 2011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD
Akshay S Desai, Robert Toto, Petr Jarolim, et al.
The New England Journal of Medicine
|
June 12, 2014
CPAP versus oxygen in obstructive sleep apnea
Daniel J Gottlieb, Naresh M Punjabi, Reena Mehra, et al.
European Journal of Heart Failure
|
November 17, 2017
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial
Muthiah Vaduganathan, Baljash Cheema, Erin Cleveland, et al.
Circulation. Heart Failure
|
December 16, 2017
Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance
Tonje Thorvaldsen, Brian L Claggett, Amil Shah, et al.
Journal of the American Heart Association
|
April 25, 2016
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Marwa A Sabe, Brian Claggett, Emmanuel A Burdmann, et al.
Circulation. Cardiovascular Quality and Outcomes
|
November 21, 2013
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)
Esteban Escolar, Gervasio A Lamas, Daniel B Mark, et al.
Frontiers in Cardiovascular Medicine
|
April 7, 2022
Artificial Intelligence Advancements in the Cardiovascular Imaging of Coronary Atherosclerosis
Pedro Covas, Eison De Guzman, Ian Barrows, et al.
JACC. Heart Failure
|
April 12, 2014
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction)
Eldrin F Lewis, Yanhong Li, Marc A Pfeffer, et al.
Page
of 128
Search research articles
Search
Showing results (1091-1100 of 1,275) with videos related to
Sort By:
Page
of 128
Nucleic Acids Research
|
November 26, 1999
A multiple-capillary electrophoresis system for small-scale DNA sequencing and analysis
J Zhang, K O Voss, D F Shaw, et al.
American Heart Journal
|
August 25, 2015
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus
Eldrin F Lewis, Brian Claggett, Patrick S Parfrey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 9, 2011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD
Akshay S Desai, Robert Toto, Petr Jarolim, et al.
The New England Journal of Medicine
|
June 12, 2014
CPAP versus oxygen in obstructive sleep apnea
Daniel J Gottlieb, Naresh M Punjabi, Reena Mehra, et al.
European Journal of Heart Failure
|
November 17, 2017
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial
Muthiah Vaduganathan, Baljash Cheema, Erin Cleveland, et al.
Circulation. Heart Failure
|
December 16, 2017
Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance
Tonje Thorvaldsen, Brian L Claggett, Amil Shah, et al.
Journal of the American Heart Association
|
April 25, 2016
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Marwa A Sabe, Brian Claggett, Emmanuel A Burdmann, et al.
Circulation. Cardiovascular Quality and Outcomes
|
November 21, 2013
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)
Esteban Escolar, Gervasio A Lamas, Daniel B Mark, et al.
Frontiers in Cardiovascular Medicine
|
April 7, 2022
Artificial Intelligence Advancements in the Cardiovascular Imaging of Coronary Atherosclerosis
Pedro Covas, Eison De Guzman, Ian Barrows, et al.
JACC. Heart Failure
|
April 12, 2014
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction)
Eldrin F Lewis, Yanhong Li, Marc A Pfeffer, et al.
Page
of 128